KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Progyny (PGNY) EPS (Weighted Average and Diluted) (2019 - 2025)

Progyny (PGNY) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.14 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 16.67% to $0.14 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.65 through Dec 2025, up 14.04% year-over-year, with the annual reading at $0.65 for FY2025, 14.04% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.14 at Progyny, down from $0.15 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.19 in Q2 2021, with the low at $0.03 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.14, with a median of $0.15 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 2000.0% in 2021, then plummeted 80.0% in 2022.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.15 in 2021, then tumbled by 80.0% to $0.03 in 2022, then surged by 333.33% to $0.13 in 2023, then fell by 7.69% to $0.12 in 2024, then rose by 16.67% to $0.14 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.14, $0.15, and $0.19 for Q4 2025, Q3 2025, and Q2 2025 respectively.